Señales en vivo de FATE | Maximiza tus Ganancias con Getagraph.com

COMPRAR 117791 min ago

@ $6.43

Emitido: 14 feb 2024 @ 15:38

Retorno: -34.45%

Señal anterior: feb 14 - 13:20

Señal anterior: Vender

Retorno: -1.30 %

Live Chart Being Loaded With Signals

Commentary (6 may 2024 @ 11:49):

Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide...

Stats
Volumen de hoy	595 736
Volumen promedio	2.62M
Capitalización de mercado	479.74M
EPS	$0 ( 2024-05-01 )
Próxima fecha de ganancias	( $-0.480 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-2.57
ATR14	$0.00600 (0.14%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-21	Redmile Group, Llc	Buy	3 636 364	Pre-Funded Warrants to Purchase Common Stock
2024-03-04	Dulac Edward J Iii	Sell	2 447	Common Stock
2024-02-01	Wolchko J Scott	Buy	500 000	Stock Option (Right to Buy)
2024-02-01	Tahl Cindy	Buy	425 000	Stock Option (Right to Buy)
2024-02-01	Dulac Edward J Iii	Buy	425 000	Stock Option (Right to Buy)

INSIDER POWER
40.70
Last 99 transactions
Buy: 17 254 718 \| Sell: 8 388 589

Volumen Correlación

Largo: 0.42 (neutral)

Corto: 0.02 (neutral)

Signal:(80.737) Neutral

Fate Therapeutics Inc Correlación

10 Correlaciones Más Positivas
STRC	0.974
ONCS	0.971
WISA	0.97
TTCF	0.969
IMRX	0.968
LUMO	0.964
GROM	0.961
VIRX	0.957
MEDS	0.956
IMCC	0.956

10 Correlaciones Más Negativas
NWFL	-0.96
IBEX	-0.95
MNKD	-0.947
PWOD	-0.942
LRFC	-0.935
HZNP	-0.934
PDD	-0.931
XOMAO	-0.931
ISIG	-0.93
IMMR	-0.93

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Fate Therapeutics Inc Correlación - Moneda/Commodity

0.43
( neutral )

0.40
( neutral )

0.00
( neutral )

0.47
( neutral )

0.41
( neutral )

-0.47
( neutral )

Fate Therapeutics Inc Finanzas

Annual	2023
Ingresos:	$63.53M
Beneficio Bruto:	$45.25M (71.22 %)
EPS:	$-1.640

FY	2023
Ingresos:	$63.53M
Beneficio Bruto:	$45.25M (71.22 %)
EPS:	$-1.640

FY	2022
Ingresos:	$96.30M
Beneficio Bruto:	$82.54M (85.71 %)
EPS:	$-2.63

FY	2021
Ingresos:	$55.85M
Beneficio Bruto:	$55.85M (100.00 %)
EPS:	$-2.24

Financial Reports:

No articles found.

Fate Therapeutics Inc

Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat multiple myeloma; FT819 to treat hematologic malignancies and solid tumors; FT536 to treat solid tumors; and FT500 for the treatment of advanced solid tumors. The company has a collaboration and option agreement with Ono Pharmaceutical Co. Ltd. for the development and commercialization of two off-the-shelf iPSC-derived CAR T-cell product candidates; strategic research collaboration and license agreement with Juno Therapeutics, Inc. to screen for and identify small molecule modulators that enhance the therapeutic properties of genetically-engineered T-cell immunotherapies; and a collaboration and option agreement with Janssen Biotech, Inc. Fate Therapeutics, Inc. was incorporated in 2007 and is headquartered in San Diego, California.

Actualizaciones en tiempo real para Fate Therapeutics Inc [FATE]

Upcoming Earnings Alert